Yes it's getting very interesting.
Since a change of directors in 2009 the financial position has changed dramatically.
Year End 2009 saw a total comprehensive loss of $737,971,000
and earnings per share of minus 0.012
The new management turned it around completely for YE 2010 - $194,813,000 profit and earnings per share of positive 0.003
So YE 2011 should also be impressive as the quarterlies have shown total operating and investing cash flows as
30/9/10 -($943,000)
31/12/10 -($14,000)
31/3/11 +$759,000
30/6/11 +$904,000
Receipts from customers
30/9/10 $2,760,000
31/12/10 $6,673,000
31/3/11 $4,975,000
30/6/11 $7,234,000
And cash held has increased from $1,061,000 as of 30/9/10
to $2,701,000 as of 30/6/11
With a market cap of $7,000,000 ... I totally agree elbows, the current share price is a great buying opportunity. And if the seller at .001 with the huge order (9/10ths of the sells) changes their mind ... the SP could appreciate 100% very quickly.
- Forums
- ASX - By Stock
- AFT
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly , page-3
Featured News
Add AFT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.020M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AFT (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online